Anil Gulati
Affiliations: | Bioengineering | University of Illinois at Chicago, Chicago, IL, United States |
Area:
Biomedical Engineering, Neuroscience Biology, PharmacyGoogle:
"Anil Gulati"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ramos MD, Briyal S, Prazad P, et al. (2021) Neuroprotective Effect of Sovateltide (IRL 1620, PMZ 1620) in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy. Neuroscience. 480: 194-202 |
| Kasala S, Briyal S, Prazad P, et al. (2020) Exposure to Morphine and Caffeine Induces Apoptosis and Mitochondrial Dysfunction in a Neonatal Rat Brain. Frontiers in Pediatrics. 8: 593 |
| Ranjan AK, Briyal S, Gulati A. (2020) Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke. Scientific Reports. 10: 12737 |
| Ranjan AK, Briyal S, Khandekar D, et al. (2020) Sovateltide (IRL-1620) affects neuronal progenitors and prevents cerebral tissue damage after ischemic stroke. Canadian Journal of Physiology and Pharmacology |
| Gupta B, Hornick MG, Briyal S, et al. (2020) Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy. Frontiers in Pediatrics. 8: 65 |
| Briyal S, Ranjan AK, Hornick MG, et al. (2020) Author Correction: Anti-apoptotic activity of ET receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia. Scientific Reports. 10: 2992 |
| Briyal S, Ranjan AK, Hornick MG, et al. (2019) Anti-apoptotic activity of ET receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia. Scientific Reports. 9: 10439 |
| Cifuentes EG, Hornick MG, Havalad S, et al. (2018) Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion. Frontiers in Pediatrics. 6: 310 |
| Gulati A, Hornick MG, Briyal S, et al. (2018) A novel neuroregenerative approach using ET(B) receptor agonist, IRL-1620, to treat CNS disorders. Physiological Research. 67: S95-S113 |
| Amlani A, Hornick MG, Cooper K, et al. (2017) Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor Expression in the Brains of Dams but Not Their Offspring. Developmental Neuroscience. 39: 498-506 |